Models for predicting non‐sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system
Identifieur interne : 006D93 ( Main/Exploration ); précédent : 006D92; suivant : 006D94Models for predicting non‐sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system
Auteurs : B. Unal [États-Unis] ; A. S. Gur [États-Unis] ; O. Kayiran [États-Unis] ; R. Johnson [États-Unis] ; G. Ahrendt [États-Unis] ; M. Bonaventura [États-Unis] ; A. Soran [États-Unis]Source :
- International Journal of Clinical Practice [ 1368-5031 ] ; 2008-11.
Abstract
Background: Although delayed axillary lymph node dissection is the gold standard for evaluating axillary status after identification of a positive sentinel lymph node (SLN), between 40% and 70% of sentinel lymph node positive patients will have negative non‐sentinel nodes and undergo a non‐therapeutic axillary dissection. Accurate estimates of the likelihood of additional disease in the axilla can assist decision‐making about further treatment. To predict non‐SLN metastases in patients with a positive SLN biopsy, four different nomograms have been created.
Url:
DOI: 10.1111/j.1742-1241.2008.01887.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003454
- to stream Istex, to step Curation: 003454
- to stream Istex, to step Checkpoint: 001052
- to stream Main, to step Merge: 006F02
- to stream Main, to step Curation: 006D93
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Models for predicting non‐sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system</title><author><name sortKey="Unal, B" sort="Unal, B" uniqKey="Unal B" first="B." last="Unal">B. Unal</name></author><author><name sortKey="Gur, A S" sort="Gur, A S" uniqKey="Gur A" first="A. S." last="Gur">A. S. Gur</name></author><author><name sortKey="Kayiran, O" sort="Kayiran, O" uniqKey="Kayiran O" first="O." last="Kayiran">O. Kayiran</name></author><author><name sortKey="Johnson, R" sort="Johnson, R" uniqKey="Johnson R" first="R." last="Johnson">R. Johnson</name></author><author><name sortKey="Ahrendt, G" sort="Ahrendt, G" uniqKey="Ahrendt G" first="G." last="Ahrendt">G. Ahrendt</name></author><author><name sortKey="Bonaventura, M" sort="Bonaventura, M" uniqKey="Bonaventura M" first="M." last="Bonaventura">M. Bonaventura</name></author><author><name sortKey="Soran, A" sort="Soran, A" uniqKey="Soran A" first="A." last="Soran">A. Soran</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:707DE9468C71326EF19D6BDB9F603A9EF0F5BA5F</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1111/j.1742-1241.2008.01887.x</idno><idno type="url">https://api.istex.fr/document/707DE9468C71326EF19D6BDB9F603A9EF0F5BA5F/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003454</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003454</idno><idno type="wicri:Area/Istex/Curation">003454</idno><idno type="wicri:Area/Istex/Checkpoint">001052</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001052</idno><idno type="wicri:doubleKey">1368-5031:2008:Unal B:models:for:predicting</idno><idno type="wicri:Area/Main/Merge">006F02</idno><idno type="wicri:Area/Main/Curation">006D93</idno><idno type="wicri:Area/Main/Exploration">006D93</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Models for predicting non‐sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system</title><author><name sortKey="Unal, B" sort="Unal, B" uniqKey="Unal B" first="B." last="Unal">B. Unal</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, Magee‐Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Gur, A S" sort="Gur, A S" uniqKey="Gur A" first="A. S." last="Gur">A. S. Gur</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, Magee‐Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Kayiran, O" sort="Kayiran, O" uniqKey="Kayiran O" first="O." last="Kayiran">O. Kayiran</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, Magee‐Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Johnson, R" sort="Johnson, R" uniqKey="Johnson R" first="R." last="Johnson">R. Johnson</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, Magee‐Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Ahrendt, G" sort="Ahrendt, G" uniqKey="Ahrendt G" first="G." last="Ahrendt">G. Ahrendt</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, Magee‐Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Bonaventura, M" sort="Bonaventura, M" uniqKey="Bonaventura M" first="M." last="Bonaventura">M. Bonaventura</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, Magee‐Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Soran, A" sort="Soran, A" uniqKey="Soran A" first="A." last="Soran">A. Soran</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, Magee‐Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">International Journal of Clinical Practice</title><title level="j" type="alt">INTERNATIONAL JOURNAL OF CLINICAL PRACTICE</title><idno type="ISSN">1368-5031</idno><idno type="eISSN">1742-1241</idno><imprint><biblScope unit="vol">62</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1785">1785</biblScope><biblScope unit="page" to="1791">1791</biblScope><biblScope unit="page-count">7</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2008-11">2008-11</date></imprint><idno type="ISSN">1368-5031</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1368-5031</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Background: Although delayed axillary lymph node dissection is the gold standard for evaluating axillary status after identification of a positive sentinel lymph node (SLN), between 40% and 70% of sentinel lymph node positive patients will have negative non‐sentinel nodes and undergo a non‐therapeutic axillary dissection. Accurate estimates of the likelihood of additional disease in the axilla can assist decision‐making about further treatment. To predict non‐SLN metastases in patients with a positive SLN biopsy, four different nomograms have been created.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Unal, B" sort="Unal, B" uniqKey="Unal B" first="B." last="Unal">B. Unal</name></region><name sortKey="Ahrendt, G" sort="Ahrendt, G" uniqKey="Ahrendt G" first="G." last="Ahrendt">G. Ahrendt</name><name sortKey="Bonaventura, M" sort="Bonaventura, M" uniqKey="Bonaventura M" first="M." last="Bonaventura">M. Bonaventura</name><name sortKey="Gur, A S" sort="Gur, A S" uniqKey="Gur A" first="A. S." last="Gur">A. S. Gur</name><name sortKey="Johnson, R" sort="Johnson, R" uniqKey="Johnson R" first="R." last="Johnson">R. Johnson</name><name sortKey="Kayiran, O" sort="Kayiran, O" uniqKey="Kayiran O" first="O." last="Kayiran">O. Kayiran</name><name sortKey="Soran, A" sort="Soran, A" uniqKey="Soran A" first="A." last="Soran">A. Soran</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006D93 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006D93 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:707DE9468C71326EF19D6BDB9F603A9EF0F5BA5F
|texte= Models for predicting non‐sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system
}}
| This area was generated with Dilib version V0.6.31. |  |